Streaming video is here to stay, regardless of what trend is dominating the stock market. While these stocks can ebb and flow with quite a bit of volatility, it hasn’t stopped investors from looking for the best streaming stocks to buy. This business is not an easy one, either. While the back-end technology for streaming
The cannabis realm has piqued investor interest and is well on its way to carving an indelible spot in the investment landscape. As the industry flourishes, the best cannabis stocks to buy have emerged not by chasing mere profits but by committing to sustainable trajectories. Moreover, while the much-anticipated crescendo of federal-level legalization is still
It has been over 50 years since humankind first went to space and stepped on the moon, and space remains a perilous frontier for both people and companies. While scientists and science fiction enthusiasts expected space to be the largest industry of the 21st century, space companies have instead languished in relative obscurity. For a
Merck (NYSE:MRK) has consistently delivered impressive financial results, built a robust product portfolio, and demonstrated an unwavering commitment to research and development. Given this, I think Merck could be a good stock to consider here. When we look at the Health Care Select Sector SPDR Fund (NYSEARCA:XLV) relative to the SPDR S&P 500 ETF (NYSEARCA:SPY),
In an era when data reigns supreme, few sectors shine as brightly as that of machine learning. Leading machine learning stocks are carving out a notable niche for tech-savvy investors. These aren’t merely fleeting trends or temporary boosts. The high-potential stocks we’re about to discuss represent the nexus of innovation and opportunity. While “must-buy machine
DNA is as fundamental to biotechnology as it is to biology itself. From synthetic biology to pharmaceuticals, making and using DNA is usually a necessary first step in bringing a biotech product to market. That makes the leading DNA stocks foundational to the whole biotech industry. And it means the best DNA stocks can have
In this article COIN DNUT JD MAXN LRCX NXPI UBSG-CH NWSA Follow your favorite stocksCREATE FREE ACCOUNT Alibaba Group sign is seen at the World Artificial Intelligence Conference (WAIC) in Shanghai, China July 6, 2023. Aly Song | Reuters Check out the companies making headlines in midday trading. News Corp — The media company’s shares
For a hot minute, Wall Street loved electric vehicle (EV) battery technology company QuantumScape (NYSE:QS). Then, financial traders turned against the company and QS stock quickly coughed up its gains. Frankly, it’s just too risky to invest in QuantumScape now. Don’t get the wrong idea. The investing community is fickle, and any stock is susceptible
It’s the height of summer vacation season, and the stock market is taking a breather after its major rally earlier in the year. For active traders, much of the excitement has moved to penny stocks, with many low-priced equities making huge moves in recent weeks. Investors should avoid the urge to go plunging too aggressively
SoFi Technologies (NASDAQ:SOFI) is a banking sector disruptor that’s garnered a lot of attention on Wall Street. Opinions vary, but one notable theme among analysts is that SOFI stock looks overvalued. I tend to agree, and while I like SoFi Technologies as a company, I recommend that prospective investors wait for the share price to come
Following what billionaires and investing gurus are doing isn’t a bad strategy. Looking at their top stocks to buy is at least a good first step for beginning your investment journey. But if always blindly buying what they bought was a successful strategy, we’d all be millionaires. Quite often, the smartest guys in the room are
Navigating the kaleidoscope of the stock market, it’s clear that the reasons for a short-term rally are as diverse as the companies themselves. Some stocks rebound with gusto, while others catch the investor’s eye due to the sheer brilliance of their outlooks, morphing into must-buy top performers. However, these top stocks for 2023 stand out
Investors continue to rush into AI’s potential trillion-dollar opportunity, but some caution is due as some AI stocks over-inflate amidst competition from tech giants. Indeed, the valuations of many AI stocks now carry prices in years and years of growth. Thus, even if this opportunity materializes, it’s unclear how much upside will be left for
Oil prices are on the rise and with it, prices at the gas pump are rising too. There’s not much consumers may be able to do about that this year. But it’s a reminder of the key benefit to electric vehicle (EV) ownership. That makes it a good time to look at the top EV
A Six Flags Great Adventure “Clean Team” crew member disinfects the Wonder Woman: Lasso of Truth ride every 30 minutes. Kenneth Kiesnoski/CNBC Check out the companies making headlines in premarket trading. UBS — Stock in the Swiss bank ticked up 4.6% before the opening bell following news that UBS ended a $10 billion loss protection
In 2022, the idea of a massive online augmented or virtual reality gathering place became mainstream. We even saw Super Bowl ads devoted to the concept. A year later, however, enthusiasm has cooled and it’s time to sell these metaverse stocks to avoid in August. As it would turn out, it is taking a while
With the world going green, some of the most explosive opportunities can be found in hydrogen stocks. Analysts at Markets and Markets say the market could be worth $410.6. billion by 2030. Goldman Sachs (NYSE:GS) says we could be looking at a $1 trillion opportunity by 2050. Meanwhile, the U.S. Department of Energy just said
In hindsight, Meta Platforms (NASDAQ:META) stock was clearly a “can’t miss” contrarian opportunity late last year, when the tech giant traded for as little as $88.09 per share. Since then, META stock has rallied by around 246%, thanks to favorable company-related and sector-related developments. However, while it may be a longtime before the Facebook and
Payment processing specialist PayPal (NASDAQ:PYPL) is a formerly favored company on Wall Street that’s now in a state of decline. PYPL stock gets a “D” grade because, even if some of PayPal’s financial metrics seem adequate, there are definitely cracks in the foundation. Not long ago, UBS analysts cut their price target on PayPal shares from
Chimerix (NASDAQ:CMRX), like most clinical-stage biotech stocks, is without question a high-risk play. Yet in contrast to other biotechs, where high potential rewards can outweigh this high risk, that is not necessarily the case here with CMRX stock. Sure, on paper, Chimerix’s future prospects appear very promising. Last year, the company sold a treatment that